RT Journal Article
SR Electronic
T1 Obesity, walking pace and risk of severe COVID-19: Analysis of UK Biobank
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.10.20150003
DO 10.1101/2020.07.10.20150003
A1 Yates, Thomas
A1 Razieh, Cameron
A1 Zaccardi, Francesco
A1 Seidu, Samuel
A1 Davies, Melanie J
A1 Khunti, Kamlesh
YR 2020
UL http://medrxiv.org/content/early/2020/07/11/2020.07.10.20150003.abstract
AB Obesity is an emerging risk factor for coronavirus disease-2019 (COVID-19). Simple measures of physical fitness, such as self-reported walking pace, could also be important risk factors, but have not been well documented. This analysis includes 414,201 UK Biobank participants with complete covariate and linked COVID-19 data. We analysed the risk of severe (in-hospital) COVID-19 across categories of obesity status and walking pace. As of June 20th 2020 there were 972 cases of severe COVID-19 that had occurred within the cohort. Compared to normal weight individuals, the adjusted odds ratio (OR) for severe COVID-9 in those with obesity was 1.49 (1.24, 1.78). Compared to those with a brisk walking pace, the OR in slow walkers was 1.84 (1.49, 2.27). Slow walkers had the highest risk of severe COVID-19 regardless of obesity status. For example, compared to normal weight brisk walkers, the odds of severe COVID-19 in obese brisk walkers was 1.39 (0.99, 1.98), whereas the odds in normal weight slow walkers was 2.48 (1.56, 3.93). Self-reported walking pace, a simple measure of functional fitness, appears to be a risk factor for severe COVID-19 that is independent of obesity. This may help inform simple pragmatic public health risk stratification and preventative strategies.Competing Interest StatementProf Kamlesh Khunti declares membership of the independent SAGE groupFunding StatementThis research was supported by the National Institute for Health Research (NIHR) Leicester Biomedical Research Centre and the NIHR Applied Research Collaboration East Midlands. The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:North West Multi-centre Research Ethics Committee (MREC),All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available via UK Biobank https://www.ukbiobank.ac.uk/